Gynecology & Obstetrics
Open Access
ISSN: 2161-0932
ISSN: 2161-0932
Cheng-Tao Lin
Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University College of Medicine,
Taoyuan
People's Republic of China
Case Report
Efficacy of Imiquimod Cream Administered Intraperitoneally for Ovarian Metastases in Colorectal Cancer
Author(s): Yi-Hao Lin, Fu-Chieh Chu, Hsiu-Huei Peng, Hsuan Weng and Cheng-Tao LinYi-Hao Lin, Fu-Chieh Chu, Hsiu-Huei Peng, Hsuan Weng and Cheng-Tao Lin
In this case report, we sought to determine the efficacy of intraperitoneal Imiquimod cream for the treatment of persistent ovarian metastases in colorectal cancer after Avastin-based chemotherapy failure. Topical Imiquimod cream is an immune response modifier. It could trigger skin Langerhan cells (naïve dendritic cells) as the priming responsive cell type and initiate a strong Th1-switched anti-tumor cellular immune response. This is a 50-year-old woman with rectal cancer with liver, lung, left adrenal gland and ovarian metastasis, and pelvic carcinomatosis. CEA level decreased after the initial optimal debulking surgery and 12 cycles of chemotherapy. However, CEA level persistently elevated, and CT scan showed progressed carcinomatosis, malignant ascites and diffused metastasis. After intraperitoneal immunomodulatory therapy (IMT) administration with intraperitoneal Interleuki.. View More»
DOI:
10.4172/2161-0932.1000415